ResMed Story Overview

RMD -- USA Stock  

USD 106.76  0.96  0.91%

Macroaxis does not monitor all media channels or aggregates social signals for ResMed. But even though we do not provide professional-grade financial sentiment analysis on ResMed, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for ResMed. Additionally take a look at ResMed Hype Analysis, ResMed Correlation and ResMed Performance.
Rare Stocks Roar Again After Tech Valuation ResMed Inc.
ResMed Inc. has noticeable measure of stock volatility, for this average true range is an exponential moving average of the True Ranges.

Read More...   

Story Momentum

This article from nasdaqtimes.com published on 29 of December contributed to the next trading period price escalation.The trading delta at closing time to the next next day price was 0.99% . The trading delta at closing time when the story was published to current price is 26.06% .

Similar stores for ResMed

a day ago at www.macroaxis.com 
Sale by Don Darkin of 25442 shares of ResMed
Macroaxis News
Filed transaction by Resmed Inc officer. General open market or private sale of non-derivative or derivative security
few days ago at http://colbypost.com 
ResMed Inc. Momentum in Focus as Target Weight For Portfolio Reaches 0.07000
news
Colby PostFull coverage
over a week ago at www.macroaxis.com 
Acquisition by Michael Farrell of 27199 shares of ResMed subject to Rule 16b-3
Macroaxis News
Filed transaction by Resmed Inc officer. Grant, award or other acquisition pursuant to Rule 16b-3
over a week ago at www.macroaxis.com 
ResMed exotic insider transaction detected
Macroaxis News
Filed transaction by Resmed Inc director. Unconventional Insider trading
over two weeks ago at www.macroaxis.com 
Acquisition by Christopher Roberts of 2442 shares of ResMed subject to Rule 16b-3
Macroaxis News
Filed transaction by Resmed Inc director. Grant, award or other acquisition pursuant to Rule 16b-3
over two weeks ago at www.macroaxis.com 
Exercise or conversion by Rich Sulpizio of 28403 shares of ResMed subject to Rule 16b-3
Macroaxis News
Filed transaction by Resmed Inc director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
over three weeks ago at www.macroaxis.com 
Exercise or conversion by Brett Sandercock of 4000 shares of ResMed subject to Rule 16b-3
Macroaxis News
Filed transaction by Resmed Inc officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
over three weeks ago at http://danversrecord.com 
Resmed Inc Heading in the Right Direction
news
Danvers RecordFull coverage
over three weeks ago at www.macroaxis.com 
Sale by David Pendarvis of 5500 shares of ResMed
Macroaxis News
Filed transaction by Resmed Inc officer. General open market or private sale of non-derivative or derivative security
over a month ago at www.macroaxis.com 
ResMed exotic insider transaction detected
Macroaxis News
Filed transaction by Resmed Inc director. Unconventional Insider trading
over a month ago at www.macroaxis.com 
Exercise or conversion by Jacobsen Stein of 37500 shares of ResMed subject to Rule 16b-3
Macroaxis News
Filed transaction by Resmed Inc officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
over two months ago at http://mtastar.com 
Sale by Hollingshead James of 600 shares of ResMed
news
Filed transaction by Resmed Inc officer. General open market or private sale of non-derivative or derivative security
over three months ago at www.macroaxis.com 
ResMed exotic insider transaction detected
Macroaxis News
Filed transaction by Resmed Inc director. Unconventional Insider trading

Did you try this?

Run Efficient Frontier Now
   

Efficient Frontier

Plot and analyze your portfolio and positions against risk-return landscape of the market.
All  Next Launch Efficient Frontier

Return On Equity

Return On Equity Comparative Analysis
ResMed is rated third in return on equity category among related companies. Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how effecently a company utilizes investments to generate income.

Peers

ResMed Related Equities
VAR  0.93 %   
0%
68.0%
RMD  0.91 %   
0%
66.0%
TFX  0.73 %   
0%
53.0%
SYK  0.22 %   
0%
16.0%
XRAY  0.11 %   
8.0%
0%
DGX  0.33 %   
24.0%
0%
HOLX  0.49 %   
36.0%
0%
COO  0.79 %   
58.0%
0%
DXCM  1.19 %   
87.0%
0%
BSX  1.37 %   
100.0%
0%
Additionally take a look at ResMed Hype Analysis, ResMed Correlation and ResMed Performance. Please also try Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.